NCT01909050View on ClinicalTrials.gov

Immune Response in Celiac Disease on In-vitro Gluten Challenge

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

January 31, 2018

Study Completion Date

March 31, 2018

Conditions
Celiac Disease
Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT01909050 - Immune Response in Celiac Disease on In-vitro Gluten Challenge | Biotech Hunter | Biotech Hunter